Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Stemtech (STEK) EBIAT (2016 - 2025)

Stemtech's EBIAT history spans 6 years, with the latest figure at -$809406.0 for Q3 2025.

  • On a quarterly basis, EBIAT rose 30.9% to -$809406.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.0 million, a 43.59% increase, with the full-year FY2024 number at -$3.8 million, up 30.58% from a year prior.
  • EBIAT hit -$809406.0 in Q3 2025 for Stemtech, down from -$296280.0 in the prior quarter.
  • Over the last five years, EBIAT for STEK hit a ceiling of $17.4 million in Q3 2022 and a floor of -$25.0 million in Q2 2022.
  • Historically, EBIAT has averaged -$1.4 million across 5 years, with a median of -$809406.0 in 2025.
  • The widest YoY moves for EBIAT: up 427.46% in 2022, down 3129.07% in 2022.
  • Tracing STEK's EBIAT over 5 years: stood at -$873152.0 in 2021, then skyrocketed by 48.02% to -$453827.0 in 2022, then plummeted by 310.35% to -$1.9 million in 2023, then surged by 78.87% to -$393445.0 in 2024, then crashed by 105.72% to -$809406.0 in 2025.
  • Business Quant data shows EBIAT for STEK at -$809406.0 in Q3 2025, -$296280.0 in Q2 2025, and -$1.5 million in Q1 2025.